Cognitive Behavior Therapy for Treating Anxiety in People With Dementia
Launched by BAYLOR COLLEGE OF MEDICINE · Jan 4, 2008
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
Dementia is an illness that causes memory problems; changes in behavior; and difficulty with thinking, making decisions, and carrying out daily activities. Many people with dementia also have anxiety, and yet very little is known about effective treatment strategies for anxiety in this population. Cognitive behavioral therapy (CBT) is a type of psychotherapy that is commonly used to treat anxiety. CBT involves teaching patients skills to help them manage their anxiety, such as relaxation, changing their thoughts, and problem-solving. This study will evaluate the effectiveness of CBT in trea...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Alzheimer's disease that is in the mild or moderate range according to a score of 0.5 to 2.0 on the Clinical Dementia Rating (CDR) Scale
- • Significant anxiety as defined by a score of 4 on the Neuropsychiatric Inventory (NPI)
- • Agrees to permit participation of a collateral
- • English-speaking
- Exclusion Criteria:
- • Suicidal intent
- • Current psychosis or bipolar disorder
- • History of substance abuse within 1 month prior to study entry
About Baylor College Of Medicine
Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Houston, Texas, United States
Patients applied
Trial Officials
Melinda A. Stanley, PhD
Principal Investigator
Baylor College of Medicine
Jessica Calleo, PhD
Study Director
Baylor College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials